These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 22158071

  • 1. Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells.
    Ma D, Wang J, Zhao Y, Lee WN, Xiao J, Go VL, Wang Q, Recker RR, Xiao GG.
    Pancreas; 2012 Apr; 41(3):397-408. PubMed ID: 22158071
    [Abstract] [Full Text] [Related]

  • 2. Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
    Lee WN, Guo P, Lim S, Bassilian S, Lee ST, Boren J, Cascante M, Go VL, Boros LG.
    Br J Cancer; 2004 Dec 13; 91(12):2094-100. PubMed ID: 15599384
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways.
    Zhang H, Cao R, Lee WN, Deng C, Zhao Y, Lappe J, Recker R, Yen Y, Wang Q, Tsai MY, Go VL, Xiao GG.
    J Proteome Res; 2010 Feb 05; 9(2):980-9. PubMed ID: 20035555
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression.
    Schnier JB, Nishi K, Monks A, Gorin FA, Bradbury EM.
    Biochem Biophys Res Commun; 2003 Sep 12; 309(1):126-34. PubMed ID: 12943673
    [Abstract] [Full Text] [Related]

  • 5. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B, Westergaard N.
    Biochem J; 2002 Oct 15; 367(Pt 2):443-50. PubMed ID: 12099891
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells.
    Barot S, Abo-Ali EM, Zhou DL, Palaguachi C, Dukhande VV.
    Exp Cell Res; 2019 Aug 15; 381(2):288-300. PubMed ID: 31128107
    [Abstract] [Full Text] [Related]

  • 7. SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition.
    Aguilar-Valdés A, Noriega LG, Tovar AR, Ibarra-Sánchez MJ, Sosa-Hernández VA, Maravillas-Montero JL, Martínez-Aguilar J.
    Biochem Biophys Res Commun; 2021 May 07; 552():23-29. PubMed ID: 33740661
    [Abstract] [Full Text] [Related]

  • 8. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
    Lerín C, Montell E, Nolasco T, García-Rocha M, Guinovart JJ, Gómez-Foix AM.
    Biochem J; 2004 Mar 15; 378(Pt 3):1073-7. PubMed ID: 14651477
    [Abstract] [Full Text] [Related]

  • 9. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

  • 10. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX, Zhou ZW, He ZX, Zhao RJ, Zhang X, Yang L, Zhou SF, Mao ZF.
    Drug Des Devel Ther; 2015 Nov 07; 9():349-417. PubMed ID: 25609920
    [Abstract] [Full Text] [Related]

  • 11. 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
    Wright SW, Rath VL, Genereux PE, Hageman DL, Levy CB, McClure LD, McCoid SC, McPherson RK, Schelhorn TM, Wilder DE, Zavadoski WJ, Gibbs EM, Treadway JL.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):459-65. PubMed ID: 15603973
    [Abstract] [Full Text] [Related]

  • 12. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.
    Pan ST, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Jan 17; 9():937-68. PubMed ID: 25733813
    [Abstract] [Full Text] [Related]

  • 13. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
    Latsis T, Andersen B, Agius L.
    Biochem J; 2002 Nov 15; 368(Pt 1):309-16. PubMed ID: 12186629
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M, Murata T.
    Int J Mol Med; 2015 Jun 15; 35(6):1773-8. PubMed ID: 25847529
    [Abstract] [Full Text] [Related]

  • 15. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT, Schmidt CM.
    Pancreas; 2003 Nov 15; 27(4):337-44. PubMed ID: 14576498
    [Abstract] [Full Text] [Related]

  • 16. Proteomic analysis of novel targets associated with TrkA-mediated tyrosine phosphorylation signaling pathways in SK-N-MC neuroblastoma cells.
    Jung EJ, Lee SY, Kim CW.
    Proteomics; 2013 Jan 15; 13(2):355-67. PubMed ID: 23319303
    [Abstract] [Full Text] [Related]

  • 17. Physiological control of liver glycogen metabolism: lessons from novel glycogen phosphorylase inhibitors.
    Agius L.
    Mini Rev Med Chem; 2010 Oct 15; 10(12):1175-87. PubMed ID: 20716056
    [Abstract] [Full Text] [Related]

  • 18. Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media.
    Xiao J, Lee WN, Zhao Y, Cao R, Go VL, Recker RR, Wang Q, Xiao GG.
    Pancreas; 2010 Jan 15; 39(1):e17-23. PubMed ID: 19904223
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S, Lee SH, Dean NM, McMahon M.
    Cancer Res; 2005 Jun 01; 65(11):4870-80. PubMed ID: 15930308
    [Abstract] [Full Text] [Related]

  • 20. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.
    Yan G, Li L, Tao Y, Liu S, Liu Y, Luo W, Wu Y, Tang M, Dong Z, Cao Y.
    Proteomics; 2006 Mar 01; 6(6):1810-21. PubMed ID: 16470631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.